Brief: Mustang Bio Provides Car T Cell Therapy Portfolio Updates

Mustang Bio

19/12/2022 13:37

Dec 19 (Reuters) - Fortress Biotech Inc  FBIO.O :
    * MUSTANG BIO PROVIDES CAR T CELL THERAPY PORTFOLIO UPDATES
AND
2023 ANTICIPATED MILESTONES
    * MB-106 CLINICAL TRIAL UNDER MUSTANG'S IND CONTINUES TO
ENROLL
PATIENTS
    * ADDITIONAL IND FILING AND PUBLISHED RESEARCH EXPECTED IN
2023
ACROSS PORTFOLIO

Source text for Eikon:  ID:nGNX6kYkG5 
Further company coverage:  FBIO.O 
 ((Reuters.Briefs@thomsonreuters.com))